Response to ‘The long forgotten salt factor’  by Davenport, Andrew
publication was widely reported in the UK press and
television in April 2007. One must assume that this implies
that compliance with a salt-restricted diet was considered
irrelevant or was not even considered by Davenport et al. The
editorial in the same issue of Kidney International mentions
in passing the possible benefits of salt restriction but states
there is no evidence-based medicine to support the benefit of
salt restriction in the treatment of hypertension in dialysis
patients, and implies as it is difficult to achieve because of the
high salt content in processed food, drug treatment of
hypertension is an acceptable alternative.3 Thus, the aban-
donment of salt restriction in dialysis patients in the United
Kingdom seems to have followed that of the United States. A
fact that was lamented by Scribner in 1999.4 The improve-
ment of the relevant revised Kidney Disease Outcomes
Quality Initiative guidelines 20065 seems to have fallen on
deaf ears. This suspicion is confirmed by the incredibly
minimalist paragraphs dedicated to salt restriction in the
National Institute for Health and Clinical Excellence guide-
lines on the treatment of hypertension in the United
Kingdom.6 It is of interest to note that the authors have
rediscovered a very well-known observation that intradialytic
hypotension was very much commoner in patients receiving
antihypertensive medication taken on dialysis days. A
problem rarely seen when hypertension was controlled by
dietary salt restriction alone.
The authors conclude that the benefit of strict blood
pressure control targets is not evidence based and that
attempts to reach them may be more harmful than beneficial.
The unchallenged best survival data in the world of end-stage
renal disease patients treated by hemodialysis with both long
and short hours shared one common factor—an obsessive
compliance with a 5 g per day salt intake in their popula-
tions.7,8 Furthermore, a recent study comparing equivalent
blood pressure control by salt restriction vs antihypertensive
drugs in two hemodialysis centers revealed a significantly
higher incidence of cardiovascular complications in the
center using antihypertensive agents.
If one must wait for a perfectly designed randomized
control study to disprove the superiority of salt restriction over
antihypertensive agents in the control of hypertension in end-
stage renal disease patients it will indeed be a sad state of affairs.
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To keep within the word limit, not all the information
obtained during this audit of more than 2000 adult
hemodialysis patients could be presented. As Professor
Shaldon and colleagues point out, there has been a well-
recognized association between sodium balance and blood
pressure in patients with chronic kidney disease. In a
previous audit, we have reported a relationship between
improved blood pressure control and reduced interdialytic
weight gains with negative sodium balance in chronic
hemodialysis patients.1 Our standard practice is to provide
hemodialysis patients with appropriate dietetic advice to
restrict daily dietary sodium intake to 100–120 mmol/day.
However, there have been some changes to the dialysis
population of the Royal Free Hospital, since Professor
Shaldon last worked here. The hospital now serves a
multiethnic population, with some 146 different languages
officially recognized. We accept that this does impact on
the ability of our dieticians to effectively communicate
with patients, and appropriately educate them to restrict
their dietary sodium intake.
However our paper was not about hypertension control
in hemodialysis patients, as suggested by professor
Shaldon and colleagues, but rather an audit of whether
dialysis centers achieved specified pre- and post-dialysis
blood pressure targets. There is increasing data to suggest
that simple pre- and post-hemodialysis blood pressure
measurements may not necessarily accurately reflect
interdialytic blood pressure control in hemodialysis
patients.2 This may account for the differences observed
in terms of cardiovascular risk, and blood pressure control
in the general population compared to hemodialysis
patients.3 The UK Renal Registry collects pre- and post-
hemodialysis blood pressure recordings at regular intervals
from UK kidney dialysis centers, and produces a report
ranking centers according to their compliance with pre-
and post-dialysis blood pressure targets,3 which had been
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set by the UK Renal Association standards’ committee in
2002.4 However, the UK Renal Association clinical guide-
lines committee has only recently reappraised the value of
pre- and post-dialysis blood pressure targets, and has
decided on the basis of the currently available data that no
guideline target should be recommended.5
One potential side effect of setting idealized post
hemodialysis blood pressure targets is that too high an
intradialytic ultrafiltration rate may lead to severe intradia-
lytic hypotension.6 In our study, symptomatic intradialytic
hypotension, requiring active intravenous fluid resuscita-
tion occurred in some 15% of all hemodialysis sessions.7
Intradialytic hypotension may potentially lead to myocardial
hypoperfusion, and cerebral watershed ischemia.8 The
incidence of symptomatic hypotension was associated with
greater absolute and percentage interdialytic weight gains.
Although Professor Shaldon and his colleagues suggested
that our study showed that those patients who took their
antihypertensive medication before hemodialysis suffered
greater intradialytic hypotension, this was not the case.
Interestingly whether patients took their antihypertensive
medications before dialysis or not had no impact on the
frequency of intradialytic hypotension.
We support the contention of Shaldon and colleagues
that sodium balance is important in the pathogenesis of
blood pressure control in chronic hemodialysis patients.
However, although convenient, the simple recording of
blood pressure before and following a hemodialysis session
would appear not to be an accurate reflection of
interdialytic blood pressure control.2 As such, the UK
Renal Association clinical guidelines subcommittee has
recently recognized that there is no good association
between patient survival and/or cardiovascular morbidity
and simple pre- and post-hemodialysis blood pressure
measurements, and as such has rescinded the previous
guideline targets.5 This does not imply that blood pressure
control is not important for hemodialysis patients, merely
that routine pre- and post-hemodialysis blood pressure
measurements are not sufficiently accurate assessments of
interdialytic blood pressure control, to be used to set
didactic targets.
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To the Editor: In a recent issue of Kidney International Eloot
et al.1 showed the independent effect of the factor time ‘t’ on
the adequacy of hemodialysis in a simple and smart way.
Even though the importance of t had already been stressed,2,3
its crucial role had always escaped the experimental
verification because of the difficulty in separating the role
of t from that of other variables. Furthermore, Eloot et al.1
were able to add new shadows to the many doubts and
inconsistencies about Kt/Vurea, as the standard marker for
dialysis adequacy, which had already come up in the
literature.4,5 On the contrary, the crucial role played by
t (and by diffusion), as shown by Eloot et al., leads to
a ‘unifying theory’ of the adequacy of dialysis, which puts in
agreement the kinetic theories of both small and middle
molecules, which are based on several and different
distribution volumes (single, double, and multiple pools).
The diffusive mechanism turns out to be more efficient
simply because of an increase in t: consequently, it turns out
to be more effective clinically because it increases the total
solute removals, the total cleared volumes (Kt), and the
dialyzer extraction ratios of urea, creatinine, phosphorus,
and b2-microglobulin in a statistically significant way.
1 Kt/
Vurea did not change in a statistically significant way.
1
The authors did not explain why; however, we can infer
from the data that, due to the fact that Kt increased, the only
way to keep the ratio Kt/V constant is through an increase in
V. In other words, it means that, when we prescribe a dialysis
t of 4 h, Kt will have a lower value and, consequently, V will
have a value (V0), which does not correspond to the real
distribution V of urea. This effect is amplified by the
higher and higher extraction velocities of the solute which
occur in a standard dialysis treatment, in which dialysate and
blood flows are kept higher and higher: in this situation a sort
of relativity of V with respect to the solute extraction
velocities is more evident. On the contrary, when we
prescribe a dialysis t of 6 h, Kt will have a higher value and,
consequently, V will have a value which is V0þ (V1V0);
and, increasing dialysis t to 8 h, V will have a value which is
V0þ (V1V0)þ (V2V1). In other words, with longer
dialyses, the deeper compartments of the patient’s body are
cleared in such a way that the distribution V of urea tends to
behave as a unique single pool. The same type of reasoning
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